UQCRFS1 (Ubiquinol-Cytochrome c Reductase Core Protein 1), also known as Rieske Iron-Sulfur Protein (RISP), is a nuclear-encoded mitochondrial protein that is a core component of Complex III (Cytochrome bc1 Complex) in the electron transport chain. The protein contains a 2Fe-2S iron-sulfur cluster that transfers electrons from ubiquinol to cytochrome c, essential for oxidative phosphorylation and ATP production in neurons.
Structure
Domain Architecture
...
UQCRFS1 — Ubiquinol-Cytochrome c Reductase Core Protein 1
UQCRFS1 (Ubiquinol-Cytochrome c Reductase Core Protein 1), also known as Rieske Iron-Sulfur Protein (RISP), is a nuclear-encoded mitochondrial protein that is a core component of Complex III (Cytochrome bc1 Complex) in the electron transport chain. The protein contains a 2Fe-2S iron-sulfur cluster that transfers electrons from ubiquinol to cytochrome c, essential for oxidative phosphorylation and ATP production in neurons.
Structure
Domain Architecture
UQCRFS1 is a 274-amino acid protein with:
N-terminal mitochondrial targeting sequence: Directs import into mitochondria
Rieske [2Fe-2S] cluster domain: Contains the iron-sulfur cluster for electron transfer
C-terminal helix: Anchors the protein to the inner mitochondrial membrane
Iron-Sulfur Cluster
The defining feature of UQCRFS1 is its [2Fe-2S] cluster, which:
Accepts electrons from ubiquinol
Transfers electrons to cytochrome c1
Is essential for catalytic function of Complex III[@hunte2010]
Normal Function
Electron Transport Chain
UQCRFS1 is essential for Complex III function in the electron transport chain:
Q-cycle mechanism: The bc1 complex catalyzes ubiquinol oxidation and cytochrome c reduction
Proton pumping: Generates proton gradient across inner mitochondrial membrane
ATP production: Coupled electron transfer drives oxidative phosphorylation
Apoptosis Regulation
UQCRFS1 plays a role in regulating apoptosis through:
Release of cytochrome c during intrinsic apoptosis
Interaction with Bcl-2 family proteins
Regulation of mitochondrial outer membrane permeability
Role in Disease
Mitochondrial Complex III Deficiency
UQCRFS1 mutations cause complex III deficiency, leading to[@gastaldo2022]:
Encephalomyopathy: Combined brain and muscle dysfunction
Lactic acidosis: Elevated blood lactate due to impaired oxidative phosphorylation
Failure to thrive: Growth impairment in childhood
Developmental delay: Cognitive and motor developmental delays
The severity of complex III deficiency correlates with the amount of residual UQCRFS1 function.
Leigh Syndrome
UQCRFS1 deficiency can cause Leigh syndrome, characterized by[@chen2019]:
Progressive neurodegenerative disease: Progressive loss of neurological function
Respiratory failure: Central apnea and respiratory dysfunction
Hypotonia: Reduced muscle tone
Ataxia: Coordination deficits
Encephalomyopathy
Mutations in UQCRFS1 cause various forms of encephalomyopathy:
Myopathy: Muscle weakness and fatigue
Encephalopathy: Brain dysfunction affecting cognition and behavior
Ataxia: Coordination deficits
Movement disorders: Tremor and dystonia
Neurodegeneration
The sensitivity of UQCRFS1 to oxidative stress makes it particularly vulnerable in neurodegeneration[@ibrahim2020]. Oxidative modification of the iron-sulfur cluster impairs electron transfer and contributes to neuronal death in AD and PD:
Alzheimer's disease: Impaired Complex III function contributes to amyloid pathology
Parkinson's disease: Mitochondrial dysfunction in dopaminergic neurons involves Complex III
Aging: Progressive decline in Complex III activity with age
Expression
Tissue Distribution
UQCRFS1 is expressed in all tissues with mitochondria, with highest expression in:
Brain: Particularly high in neurons with high energy demands
Heart: Continuous oxidative phosphorylation for cardiac function
Skeletal muscle: High mitochondrial content for exercise
Liver: Metabolic activity and detoxification
Kidneys: High energy requirements for ion transport
Cellular Localization
Within cells, UQCRFS1 is localized to the inner mitochondrial membrane, where it forms part of the cytochrome bc1 complex (Complex III). The protein is imported into mitochondria via a presequence and anchored to the membrane through a C-terminal transmembrane helix.
Therapeutic Targeting
Gene Therapy
Viral vector-mediated UQCRFS1 delivery to neurons represents a potential therapeutic approach for mitochondrial complex III deficiency.
Small Molecule Enhancers
Compounds that stabilize the iron-sulfur cluster or enhance complex III assembly may have therapeutic utility.
Antioxidant Strategies
Mitochondrial-targeted antioxidants may protect UQCRFS1 from oxidative damage and preserve electron transport chain function[@saruwatari2021].
[Electron Transport Chain](/mechanisms/electron-transport-chain)
[Leigh Syndrome](/diseases/leigh-syndrome)
[Mitochondria](/entities/mitochondrial-dna)
References
[Hunte C, et al. Structure of the bc1 complex and crystal architecture of the Rieske iron-sulfur protein. Biochim Biophys Acta. 2010](https://pubmed.ncbi.nlm.nih.gov/20836941/)
[Gastaldo M, et al. UQCRFS1 mutations cause mitochondrial complex III deficiency and encephalomyopathy. Nat Genet. 2022](https://pubmed.ncbi.nlm.nih.gov/35697852/)
[Chen L, et al. Mitochondrial complex III deficiency leads to neurodegeneration in models of Leigh syndrome. Cell Rep. 2019](https://pubmed.ncbi.nlm.nih.gov/31230925/)
[Wang Y, et al. Rieske iron-sulfur protein function in electron transport chain. J Bioenerg Biomembr. 2018](https://pubmed.ncbi.nlm.nih.gov/29663285/)
[Saruwatari Y, et al. Targeting mitochondrial complex III in neurodegenerative diseases. Neurobiol Dis. 2021](https://pubmed.ncbi.nlm.nih.gov/34000398/)
[Ibrahim M, et al. Oxidative stress and UQCRFS1 oxidation in neurodegeneration. Free Radic Biol Med. 2020](https://pubmed.ncbi.nlm.nih.gov/32846287/)